linked in pixel

Hematology Oncology Fellowship Associate Program Director

Dr. Finn received her medical degree from Louisiana State University School of Medicine in New Orleans. She completed residency in Internal Medicine at Earl K Long at LSU Baton Rouge where she was Chief Medical Resident. Dr. Finn completed a Hematology/Oncology fellowship at Mayo Clinic School of Graduate Medical Education in Jacksonville, FL. There she was Chief Fellow and remained on faculty of Hematology and Stem Cell Transplant as an Assistant Professor of Medicine and Medical Director of Inpatient Bone Marrow Transplant for two years. She also completed advanced training in stem cell transplant as a Mayo Clinic Scholar at the University of Minnesota.

Dr. Finn is the interim co-director of Ochsner Health System's Hematology and Stem Cell Transplant Program. She has interests in all blood disorders with a research focus in Leukemia and Myelodysplastic Syndrome. She is the Hematology Research Chair of the Precision Cancer Therapies Program. Dr. Finn is involved in medical resident and fellow education as the Associate Program Director of the Hematology/Oncology Fellowship Program at Ochsner.

Dr. Finn has a strong interest in promoting shared decision making and palliative medicine as part of her routine cancer care. She is also active in promoting health care policy changes for the fields of hematology, stem cell transplant, and cancer research through advocacy with the state and federal governments. She promotes federal support for cancer research funding and sickle cell disease policy recognition.

Selected Publications

Dholaria BR, Hammond WA, Roy V, Sher T, Vishnu P, Soyano A, Finn LE, Tun H. Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience. Leuk Lymphoma. 2018 Mar 23:1-4. [Epub ahead of print].

Finn L, Dalovisio A, Foran J. Older patients with acute myeloid leukemia: treatment challenges and future directions. Ochsner J. 2017 Winter;17(4):398-404.

Finn L, Green AR, Malhotra S. Oncology and palliative medicine: providing comprehensive care for patients with cancer. Ochsner J. 2017 Winter;17(4):393-397.

Knorr KL, Finn LE, Smith BD, Hess AD, Foran JM, Karp JE, Kaufmann SH. Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo. Stem Cells Transl Med. 2017 Mar;6(3):840-850. doi: 10.5966/sctm.2016-0034. Epub 2016 Nov 7.